TSLA, F, RIVN: EV Makers Hit Hard & LLY Alzheimer's Drug Shows Promise

Makers of electric vehicles hit hard during trading, including Tesla (TSLA), Ford (F), and Rivian (RIVN). Renita Young and Kevin Hincks discuss this, as well as which EV makers are selling automobiles that may qualify for the EV tax credit. They also go over how long it could take EV makers to fully succeed in U.S. markets. They then talk about how Eli Lilly's (LLY) experimental Alzheimer's drug lowered levels of brain plaque in patients. LLY noted that a higher dose of Remternetug had a larger effect on clearing Amyloid plaque in Alzheimer's patients. Tune in to find out more about EVs, healthcare, and the stock market today.